olmesartan medoxomil has been researched along with Chronic Kidney Failure in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamano, T; Horio, M; Imai, E; Isaka, Y; Ito, T; Iwatani, H; Kawada, N; Matsui, I; Nagasawa, Y; Tanaka, H | 1 |
| Akizawa, T; Honda, H; Niikura, K; Suzuki, R | 1 |
| Akizawa, T; Aoshima, Y; Hirai, Y; Honda, H; Hosaka, N; Michihata, T | 1 |
| Ji, L; Kawamura, T; Kohzuki, M; Xu, HL; Yoshida, K | 1 |
| Arimoto, T; Ito, M; Konta, T; Kubota, I; Miyamoto, T; Miyashita, T; Shishido, T; Takahashi, H; Takeishi, Y | 1 |
| Hinman, DJ; Manabe, S; Ogata, S; Sharyo, S | 1 |
| Fukushima, Y; Kato, M; Koike, H; Mizuno, M; Sada, T; Terashima, H | 1 |
| Kohzuki, M; Wu, XM; Xu, HL; Yoshida, K | 1 |
3 trial(s) available for olmesartan medoxomil and Chronic Kidney Failure
| Article | Year |
|---|---|
Pharmacokinetics of olmesartan medoxomil in hemodialysis patients: little effect of dialysis upon its pharmacokinetics.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Area Under Curve; Blood Pressure; Half-Life; Heart Rate; Humans; Imidazoles; Kidney Failure, Chronic; Olmesartan Medoxomil; Renal Dialysis; Tetrazoles | 2009 |
Olmesartan medoxomil treatment is associated with decreased plasma B-type natriuretic peptide levels in patients on hemodialysis.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Female; Humans; Hypertension; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Prospective Studies; Renal Dialysis; Renin; Tetrazoles | 2012 |
Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; Female; Glycation End Products, Advanced; Humans; Hypertension, Renal; Imidazoles; Inflammation; Kidney Failure, Chronic; Lysine; Male; Olmesartan Medoxomil; Oxidative Stress; Pilot Projects; Prospective Studies; Renal Dialysis; Telmisartan; Tetrazoles; Treatment Outcome | 2012 |
5 other study(ies) available for olmesartan medoxomil and Chronic Kidney Failure
| Article | Year |
|---|---|
Chronic angiotensin-converting enzyme inhibition and angiotensin II antagonism in rats with chronic renal failure.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Drug Therapy, Combination; Imidazoles; Kidney Failure, Chronic; Male; Olmesartan Medoxomil; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Thiazepines | 2002 |
Protein kinase C and extracellular signal regulated kinase are involved in cardiac hypertrophy of rats with progressive renal injury.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Heart Ventricles; Imidazoles; Kidney Failure, Chronic; Male; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Olmesartan Medoxomil; Organ Size; Protein Kinase C; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Signal Transduction; Tetrazoles | 2004 |
Renal effects of 26-week administration of olmesartan medoxomil/hydrochlorothiazide in rats.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Urea Nitrogen; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hydrochlorothiazide; Imidazoles; Kidney; Kidney Diseases; Kidney Failure, Chronic; Male; Olmesartan Medoxomil; Rats; Rats, Sprague-Dawley; Sodium Chloride Symporter Inhibitors; Tetrazoles; Toxicity Tests | 2004 |
The effect of angiotensin II receptor blockade on an end-stage renal failure model of type 2 diabetes.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Urea Nitrogen; Body Weight; Chemokine CCL2; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Imidazoles; Immunohistochemistry; Kidney Failure, Chronic; Lipids; Male; Olmesartan Medoxomil; Proteinuria; Rats; Serum Albumin; Survival Rate; Systole; Tetrazoles | 2006 |
[Effects of CS-866, an angiotensin II receptor antagonist, in 5/6 nephrectomized spontaneously hypertensive rats].
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Hypertension; Imidazoles; Kidney Failure, Chronic; Male; Nephrectomy; Olmesartan Medoxomil; Rats; Rats, Inbred SHR; Tetrazoles; Thiazepines | 2001 |